The March 22, 2010 issue of USA Today features a story on the dilemma faced by aging parents of adults with Down syndrome.
Intriguingly, the new study suggests the presence or absence of the genes used to reprogram skin cells to become the blank slate pluripotent cells makes no difference in terms of their capacity to differentiate.
The February 9, 2010 issue of The Capital Times features a story on the recent retraction of a 1998 journal article claiming a link between childhood vaccines and autism.
The long struggle to move the most versatile stem cells from the laboratory to the clinic got another boost with an $8.8 million contract award to the Waisman Clinical Biomanufacturing Facility at the University of Wisconsin-Madison.
The research of Marsha Mailick Seltzer, PhD, was recently cited by Autism Speaks Chief Science Officer Geri Dawson, Ph.D., as part of a review of major scientific advances in autism research in 2010.